Positioning for success in biopharma requires a self-critical analysis of the risk and rewards among four categories of value differentiation. The key question: How do you define yourself against the competition?
Douglas Strang
Advertisement
Articles by Douglas Strang
Advertisement
Latest Updated Articles
Beyond 2020: Building Strategic Coherence in the New Health EconomyPublished: March 11th 2016 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: Novo Nordisk's Shares Fall After Board Shake-Up
2
Roundup: Pharma Industry Raises Funding Aimed at Advancing the Development and Testing of Rare Disease Treatments
3
TrumpRx and the Dawn of Direct-to-Consumer Commercialization
4
Could DTC Programs Help Simplify the Drug-Pricing System?
5
